Management of Reduced Bone Mineral Density in HIV: Pharmacological Challenges and the Role of Exercise

Low bone mineral density is becoming more common among people living with HIV following the use of current antiretroviral therapy drugs such as tenofovir. Although pharmacological therapies used to treat low bone mineral density are associated with adverse effects and may increase the pill burden in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chisati, Enock M., Constantinou, Demitri, Lampiao, Fanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090029/
https://www.ncbi.nlm.nih.gov/pubmed/30131721
http://dx.doi.org/10.3389/fphys.2018.01074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090029/
https://www.ncbi.nlm.nih.gov/pubmed/30131721
http://dx.doi.org/10.3389/fphys.2018.01074

Ejemplares similares